Cota Inc., a New York-based analytics company focused on complex diseases, has hired Michael Doyle as chief executive officer. He was previously CEO of QPID Health, a Partners HealthCare spin-out that was among the first companies to use machine learning and statistical modeling to automate prior authorization.
Cota says its solutions enable providers, payers, and life science companies involved in diagnosing and treating complex diseases to optimize the outcomes of individual patients and lower the overall cost of the patient population served. Its system categorizes patient factors, their diseases, and intended therapies.
Earlier this year, Cota announced a $40 million Series C round of financing. That financing was led by IQVIA (NYSE: IQV) with major participation by EW Healthcare Partners. Memorial Sloan Kettering Cancer Center also participated in the round, along with existing Cota investors which include Boston Millennia Partners, Horizon Blue Cross Blue Shield of New Jersey, Hackensack Meridian Health and Atoc Holdings.
"As we continue to scale and deliver on the promise of our technology, the addition of Mike Doyle to lead our team is a significant win for our partners, customers, and oncology patients," said Andrew Pecora M.D., founder and executive chairman of Cota, in a prepared statement.
In December 2012, Doyle and his team acquired QPID Health from Partners HealthCare and Massachusetts General Hospital, and established it as a commercial company. QPID was among the first companies to use machine learning and statistical modeling to automate prior authorization. Doyle sold QPID to eviCore Healthcare in February 2016. eviCore is the nation's largest medical benefit management company providing service to over 120 health care payers, serving over 100 million patients. In December 2017, eviCore was sold to Express Scripts, the nation's largest free-standing pharmacy benefit management company, for $3.6 billion. Most recently, Cigna announced its intention to buy Express Scripts for approximately $65 billion.
Prior to joining QPID, Doyle was CEO and chairman of Medsphere Systems Corp., the developer of OpenVista, an open-source enterprise electronic health record system whose basic source code originated at the Department of Veterans Affairs (VA).
Doyle called the Cota’s patented Cota Nodal Address system a “game-changing innovation was built by oncologists and data scientists – for oncology – and it's easy to see the impact that it will make to enable precision medicine at scale."
